DADC
BEAM icon

D.A. Davidson & Co’s Beam Therapeutics BEAM Stock Holding History

D.A. Davidson & Co’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.45M Buy
100,628
+1,636
+2% +$49.4K 0.02% 554
2026
Q1 		$2.36M Buy
98,992
+109
+0.1% +$3.02K 0.01% 643
2025
Q4 		$2.74M Buy
98,883
+4,253
+4% +$109K 0.02% 563
2025
Q3 		$2.3M Buy
94,630
+8,949
+10% +$178K 0.01% 605
2025
Q2 		$1.46M Buy
85,681
+14,824
+21% +$258K 0.01% 704
2025
Q1 		$1.38M Buy
70,857
+19,448
+38% +$509K 0.01% 681
2024
Q4 		$1.27M Sell
51,409
-2,438
-5% -$62.2K 0.01% 689
2024
Q3 		$1.32M Buy
53,847
+4,222
+9% +$109K 0.01% 677
2024
Q2 		$1.16M Buy
49,625
+5,672
+13% +$139K 0.01% 687
2024
Q1 		$1.45M Buy
43,953
+5,676
+15% +$177K 0.01% 616
2023
Q4 		$1.04M Buy
38,277
+11,732
+44% +$291K 0.01% 702
2023
Q3 		$638K Buy
26,545
+8,321
+46% +$223K 0.01% 819
2023
Q2 		$582K Buy
18,224
+2,264
+14% +$73.5K 0.01% 875
2023
Q1 		$489K Buy
15,960
+3,922
+33% +$155K 0.01% 899
2022
Q4 		$471K Sell
12,038
-342
-3% -$15.3K 0.01% 868
2022
Q3 		$590K Buy
12,380
+295
+2% +$16.8K 0.01% 761
2022
Q2 		$468K Buy
12,085
+454
+4% +$18K 0.01% 843
2022
Q1 		$666K Buy
11,631
+1,333
+13% +$87.4K 0.01% 775
2021
Q4 		$821K Hold
10,298
– – 0.01% 709
2021
Q3 		$896K Buy
+10,298
New +$1.03M 0.01% 659

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

D.A. Davidson & Co's BEAM Position: Q2 2026 in Review

D.A. Davidson & Co increased its Beam Therapeutics (BEAM) stake by 1.7% in Q2 2026, buying an estimated $49.4K and bringing the position to 100,628 shares worth $3.45M. The position accounts for 0.02% of the portfolio, ranked #554.

D.A. Davidson & Co first reported a position in BEAM in Q3 2021 and has held it in 20 quarters since. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • D.A. Davidson & Co held 100,628 shares of Beam Therapeutics worth $3.45M as of Q2 2026.
  • D.A. Davidson & Co bought 1,636 Beam Therapeutics shares in Q2 2026, an estimated $49.4K.
  • Beam Therapeutics made up 0.02% of D.A. Davidson & Co's portfolio in Q2 2026, its #554 holding.
  • D.A. Davidson & Co first reported a position in Beam Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.